Stanley C. Erck, President and CEO at NOVAVAX INC (NVAX), sold 70,458 shares at $166.98 ($12.4M) on 2021-10-04, disclosed to the SEC on 2021-10-05.
Open-market sale of $12.4M NVAX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $166.98 | 1,392 | $232K | 1.9% |
| 2 | $166.98 | 1,392 | $232K | 1.9% |
| 3 | $172.36 | 3,746 | $646K | 5.2% |
| 4 | $172.36 | 3,746 | $646K | 5.2% |
| 5 | $173.45 | 5,038 | $874K | 7.0% |
| 6 | $173.45 | 5,038 |
| $874K |
| 7.0% |
| 7 | $174.56 | 3,100 | $541K | 4.4% |
| 8 | $175.61 | 3,600 | $632K | 5.1% |
| 9 | $176.48 | 4,700 | $829K | 6.7% |
| 10 | $177.58 | 8,890 | $1.6M | 12.7% |
| 11 | $177.58 | 8,890 | $1.6M | 12.7% |
| 12 | $178.46 | 8,563 | $1.5M | 12.3% |
| 13 | $178.46 | 8,563 | $1.5M | 12.3% |
| 14 | $179.48 | 3,300 | $592K | 4.8% |
| 15 | $180.58 | 500 | $90K | 0.7% |
| Total | $176.03 avg | 70,458 | $12.4M | 100% |
| Filing → |
| MXCT | SELL | 2024-10-02 | $358K | — | Filing → |
| MXCT | SELL | 2024-09-05 | $383K | — | Filing → |
| NVAX | SELL | 2021-10-05 | $16.6M | — | Filing → |